• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原是1型糖尿病肾病和外周血管疾病的标志物:糖尿病控制与并发症试验/糖尿病干预和并发症流行病学研究(DCCT/EDIC)队列中的血浆纤维蛋白原及纤维蛋白原基因多态性研究

Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.

作者信息

Klein Richard L, Hunter Steven J, Jenkins Alicia J, Zheng Deyi, Semler Andrea J, Clore Jennifer, Garvey W Timothy

机构信息

Division of Endocrinology, Metabolism, and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.

出版信息

Diabetes Care. 2003 May;26(5):1439-48. doi: 10.2337/diacare.26.5.1439.

DOI:10.2337/diacare.26.5.1439
PMID:12716802
Abstract

We examined whether plasma fibrinogen levels and the beta-fibrinogen gene G(-455)-->A polymorphism were related to microvascular or macrovascular disease in patients (n = 909) with type 1 diabetes enrolled in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC). Univariate regression showed that fibrinogen levels were correlated with BMI (r = 0.15; P < 0.0001), HbA(1c) (r = 0.11; P = 0.0014), total cholesterol (r = 0.17; P < 0.0001), and LDL cholesterol (r = 0.16; P < 0.0001) in all patients. In men, but not women, waist-to-hip ratio (r = 0.20; P < 0.0001) and triglycerides (r = 0.13; P = 0.0047) also became powerful predictors of fibrinogen level; in women, but not men, fibrinogen was correlated with both diastolic (r = 0.16; P = 0.0011) and systolic (r = 0.11; P = 0.0241) blood pressure. Fibrinogen was correlated with urinary albumin excretion rates in men (r = 0.13; P = 0.0033), but not in women. In both sexes, however, the development of proteinuria (albumin excretion >300 mg/24 h) was accompanied by 1.5-fold increment in plasma fibrinogen compared with patients with normal excretion or microalbuminuria. In addition, high fibrinogen levels were associated with a lower average ankle-brachial index in women (r = -0.13; P = 0.0075), but not men. Multiple regression analyses demonstrated that plasma fibrinogen was independently correlated with high albumin excretion rate in men, and with low average ankle-brachial index in women. Fibrinogen was not correlated with the severity of retinopathy. Carotid artery intima-medial thickness was not correlated with fibrinogen, and the G(-455)-->A polymorphism in the 5' promoter region of the beta-fibrinogen gene did not influence circulating fibrinogen levels. However, the presence of the more common G(-455) allele was associated with greater intima-medial thickness in the internal carotid artery (ANCOVA P = 0.045). Last, hyperfibrinogenemia in type 1 diabetes is associated with components of the insulin resistance syndrome trait cluster, and the association is influenced by sex.

摘要

我们在参与糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究(DCCT/EDIC)的909例1型糖尿病患者中,研究血浆纤维蛋白原水平及β - 纤维蛋白原基因G(-455)→A多态性与微血管或大血管疾病是否相关。单因素回归分析显示,在所有患者中,纤维蛋白原水平与体重指数(r = 0.15;P < 0.0001)、糖化血红蛋白(r = 0.11;P = 0.0014)、总胆固醇(r = 0.17;P < 0.0001)及低密度脂蛋白胆固醇(r = 0.16;P < 0.0001)相关。在男性而非女性中,腰臀比(r = 0.20;P < 0.0001)和甘油三酯(r = 0.13;P = 0.0047)也成为纤维蛋白原水平的有力预测指标;在女性而非男性中,纤维蛋白原与舒张压(r = 0.16;P = 0.0011)和收缩压(r = 0.11;P = 0.0241)均相关。纤维蛋白原在男性中与尿白蛋白排泄率相关(r = 0.13;P = 0.0033),但在女性中无此关联。然而,在两性中,与排泄正常或微量白蛋白尿的患者相比,蛋白尿(白蛋白排泄>300 mg/24 h)的发生伴随着血浆纤维蛋白原增加1.5倍。此外,高纤维蛋白原水平与女性较低的平均踝臂指数相关(r = -0.13;P = 0.0075),但与男性无关。多因素回归分析表明,血浆纤维蛋白原在男性中与高白蛋白排泄率独立相关,在女性中与低平均踝臂指数独立相关。纤维蛋白原与视网膜病变的严重程度无关。颈动脉内膜中层厚度与纤维蛋白原无关,β - 纤维蛋白原基因5'启动子区域的G(-455)→A多态性不影响循环纤维蛋白原水平。然而,较常见的G(-455)等位基因的存在与颈内动脉内膜中层厚度增加相关(协方差分析P = 0.045)。最后,1型糖尿病中的高纤维蛋白原血症与胰岛素抵抗综合征特征簇的组分相关,且这种关联受性别影响。

相似文献

1
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.纤维蛋白原是1型糖尿病肾病和外周血管疾病的标志物:糖尿病控制与并发症试验/糖尿病干预和并发症流行病学研究(DCCT/EDIC)队列中的血浆纤维蛋白原及纤维蛋白原基因多态性研究
Diabetes Care. 2003 May;26(5):1439-48. doi: 10.2337/diacare.26.5.1439.
2
Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.1型糖尿病患者载脂蛋白C-III蛋白浓度及基因多态性:与糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究队列中微血管疾病并发症的关联
J Diabetes Complications. 2005 Jan-Feb;19(1):18-25. doi: 10.1016/j.jdiacomp.2004.04.005.
3
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.糖尿病干预与并发症流行病学研究(EDIC)。糖尿病控制与并发症试验队列长期随访的设计、实施及初步结果。
Diabetes Care. 1999 Jan;22(1):99-111. doi: 10.2337/diacare.22.1.99.
4
Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.在无明显糖尿病肾病的1型糖尿病患者中,尿白蛋白排泄与纤维蛋白原水平及蛋白S活性相关。
Wien Klin Wochenschr. 2004 Apr 30;116(7-8):240-5. doi: 10.1007/BF03041054.
5
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.1型糖尿病患者血浆唾液酸浓度与微血管和大血管并发症的关系:欧洲糖尿病并发症研究
Diabetes Care. 2001 Feb;24(2):316-22. doi: 10.2337/diacare.24.2.316.
6
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.糖尿病控制与并发症试验/糖尿病干预和并发症流行病学研究队列中与炎症和内皮功能障碍相关的危险因素及其与肾病和大血管并发症的关系。
Diabetes Care. 2008 Oct;31(10):2006-12. doi: 10.2337/dc08-0659. Epub 2008 Jul 15.
7
The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者中血管紧张素原前体值与微血管并发症的关系。
J Diabetes Complications. 1999 Jan-Feb;13(1):45-51. doi: 10.1016/s1056-8727(98)00020-8.
8
Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.血浆前激肽释放酶:1型糖尿病患者高血压和肾病的风险标志物。
Diabetes. 2003 May;52(5):1215-21. doi: 10.2337/diabetes.52.5.1215.
9
Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.2型糖尿病患者血浆尾加压素II水平升高与糖尿病视网膜病变及颈动脉粥样硬化相关。
Clin Sci (Lond). 2008 Dec;115(11):327-34. doi: 10.1042/CS20080014.
10
Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.糖尿病控制与并发症试验中糖尿病家庭长期并发症的聚类分析。糖尿病控制与并发症试验研究组。
Diabetes. 1997 Nov;46(11):1829-39.

引用本文的文献

1
Distinct association patterns of chemokine profile and cardiometabolic status in children and adolescents with type 1 diabetes and obesity.1 型糖尿病肥胖患儿趋化因子谱与心脏代谢状态的关联模式不同。
Front Endocrinol (Lausanne). 2024 Jul 23;15:1335371. doi: 10.3389/fendo.2024.1335371. eCollection 2024.
2
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.SGLT2 抑制剂通过调节糖尿病肾病小鼠的肾脏代谢重编程改善肾脏功能和形态。
J Transl Med. 2022 Sep 14;20(1):420. doi: 10.1186/s12967-022-03629-8.
3
Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients.
代谢组学和蛋白质组学在探索糖尿病视网膜病变和糖尿病肾病患者血清外泌体引起的血管内皮功能障碍机制中的整合。
Front Endocrinol (Lausanne). 2022 Mar 25;13:830466. doi: 10.3389/fendo.2022.830466. eCollection 2022.
4
Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.2019冠状病毒病大流行中的1型糖尿病:氧化应激作为与不良临床结局相关的主要病理生理机制
Antioxidants (Basel). 2021 May 9;10(5):752. doi: 10.3390/antiox10050752.
5
Coagulatory Defects in Type-1 and Type-2 Diabetes.1 型和 2 型糖尿病的凝血缺陷。
Int J Mol Sci. 2019 Dec 16;20(24):6345. doi: 10.3390/ijms20246345.
6
Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.使用易于获取的炎症标志物预测糖尿病肾病
Front Endocrinol (Lausanne). 2018 May 22;9:225. doi: 10.3389/fendo.2018.00225. eCollection 2018.
7
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.炎症标志物与 1 型糖尿病患者肾功能障碍进展的关系:不同评估窗口的评估。
Diabetes Care. 2018 Jan;41(1):128-135. doi: 10.2337/dc17-0867. Epub 2017 Nov 8.
8
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study.中国2型糖尿病合并稳定型冠状动脉疾病患者的血清纤维蛋白原与心血管事件:一项前瞻性观察研究
BMJ Open. 2017 Jun 9;7(6):e015041. doi: 10.1136/bmjopen-2016-015041.
9
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.1 型糖尿病患者慢性肾脏病的两种不同表型的证据。
Diabetologia. 2017 Jun;60(6):1102-1113. doi: 10.1007/s00125-017-4251-1. Epub 2017 Mar 29.
10
Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.2型糖尿病患者发生弥散性血管内凝血的风险:回顾性队列研究
BMJ Open. 2017 Jan 25;7(1):e013894. doi: 10.1136/bmjopen-2016-013894.